Eliot Brinton, MD, FAHA, FNLA
Erin D. Michos, MD, MHS, FACC, FAHA, FASE
The New Role of Omega-3 Fatty Acids in Reducing ASCVD Risk in Women: Expert D...
Prevention of ASCVD in Women Through Lipid Management in the New Era
Javed Butler, MD, MPH, MBA
Peter van der Meer, MD, PhD
Common Misconceptions About Iron Deficiency in Heart Failure and What to Do A...
James A. Underberg, MD, MS, FACP, FNLA
Update on ASCVD Risk Assessment and Management
George Bakris, MD
Matthew R. Weir, MD
Faiez Zannad, MD, PhD
Potassium Management Made Easy
Sergio Fazio, MD, PhD
Michael Miller, MD
Margo Minissian, PhD, ACNP
John R. Nelson, MD, FACC, FNLA, FASNC
Dialogues from the Dais: CVD Risk Red...
December 10, 2020
07:00 PM - 08:30 PM CST
Austin G. Stack, MBBCh, MD, MSc, FASN, FRCPI
Mikhail Kosiborod, MD
Management of Heart Failure: Time to Consider New Options?
Michel Farnier, MD, PhD
Børge G. Nordestgaard, MD, DMSc
Omega-3 Fatty Acids in Patients with ASCVD Risk: The Role of Icosapent Ethyl ...
Mr. Jackson Moves to Town: Overcoming Challenges to Optimizing RAASi Therapy
Robert J. Mentz, MD
Piotr Ponikowski, MD, PHD, FESC, FHFA
Don’t Be Fooled: It’s Not Just Anemia, It’s Iron Deficiency
Practical Considerations to Manage Residual ASCVD Risk
Ileana L. Piña, MD, MPH, FAHA, FACC
Giuseppe M.C. Rosano, MD, PhD, FESC, FHFA
Examining Heart Failure Management: How Can We Do Better?
Jennifer Caudle, DO
Nicole Bernard Washington, DO, MPH
Taking Care of Yourself While Taking Care of Others During COVID-19
Brian P. McDonough, MD, FAAFP
How Primary Care Clinicians on the Frontline Are Managing Patients During the...
Jay L. Koyner, MD
Sandra L. Kane-Gill, PharmD, MS, FCCM, FCCP
John A. Kellum, MD, MCCM
Early Recognition of Acute Kidney Injury: What’s the Role of Biomarkers?
C. Michael Gibson, MD, MS
Rod S. Passman, MD
Steven Steinbuhl, MD
Consumer Wearable Technology for AF Screening, Detection, and Management: Bol...